TNFSF10 and gastric adenocarcinoma: TRAIL dose–response experiments in human colorectal cancer cells (COLO-205, SW-620 and HT-29), human gastric adenocarcinoma (AGS) and human pancreatic cancer cells (PANC-1) were performed.